Firstpost
  • Home
  • Video Shows
    Vantage Firstpost America Firstpost Africa First Sports
  • World
    US News
  • Explainers
  • News
    India Opinion Cricket Tech Entertainment Sports Health Photostories
  • Asia Cup 2025
Apple Incorporated Modi ji Justin Trudeau Trending

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit
Trending:
  • PM Modi in Manipur
  • Charlie Kirk killer
  • Sushila Karki
  • IND vs PAK
  • India-US ties
  • New human organ
  • Downton Abbey: The Grand Finale Movie Review
fp-logo
Lupin launches generic ophthalmic solution in US market
Whatsapp Facebook Twitter
Whatsapp Facebook Twitter
Apple Incorporated Modi ji Justin Trudeau Trending

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit
  • Home
  • Fwire
  • Lupin launches generic ophthalmic solution in US market

Lupin launches generic ophthalmic solution in US market

FP Archives • December 20, 2014, 23:21:59 IST
Whatsapp Facebook Twitter

Drug major Lupin today said it has launched the generic version of Allergan Inc’s Zymaxid Ophthalmic Solution in the US market with 180 days of marketing exclusivity.

Advertisement
Subscribe Join Us
Add as a preferred source on Google
Prefer
Firstpost
On
Google
Lupin launches generic ophthalmic solution in US market

Drug major Lupin today said it has launched the generic version of Allergan Inc’s ZymaxidOphthalmic Solution in the US market with 180 days of marketing exclusivity.

Lupin Pharmaceuticals Inc (LPI), the company’s USsubsidiary, has launched its generic Gatifloxacin OphthalmicSolution 0.5 per cent in the US market, after having receivedthe USFDA’s final approval earlier, Lupin Ltd said in astatement.

“Zymaxid Ophthalmic Solution 0.5 per cent had annual USsales of around $62.3 million (IMS MAT June 2013 data).Lupin was the first applicant to file an abbreviated new drugapplication (ANDA) for Zymaxid Ophthalmic Solution and as suchwill be entitled to 180 days of marketing exclusivity,” thecompany said.

STORY CONTINUES BELOW THIS AD

[caption id=“attachment_1026219” align=“alignleft” width=“380”] ![Getty Images](https://images.firstpost.com/wp-content/uploads/2013/08/drugs_getty2.jpg) Getty Images[/caption]

Gatifloxacin Ophthalmic solution 0.5 percent, which isthe generic equivalent of Zymaxid Ophthalmic Solution ofAllergan, is indicated for the treatment of bacterialconjunctivitis.

More from Fwire
BCCI earned more than Rs 2,400 crore in IPL 2022, reveal documents BCCI earned more than Rs 2,400 crore in IPL 2022, reveal documents Eight Russian judokas barred from world championships after Ukraine boycott Eight Russian judokas barred from world championships after Ukraine boycott

“Having received approval earlier, we are happy to nowlaunch this product. The product is the first of theophthalmic products that Lupin is bringing to the market andbears testimony to our continued commitment to serving ourcustomers and patients by bringing high quality,” Lupin LtdManaging Director Nilesh Gupta said.

Lupin has been focusing on less competitive specialitiesspaces in the US market which includes segments like OralContraceptives, Ophthalmology and Dermatology.

TheMumbai-based company has already done over 10 filings with theUS FDA for ophthalmological products.

The company’s cumulative ANDA filings with the US FDA asof June 30, 2013 stood at 177, with the company havingreceived 86 approvals to date.

Shares of Lupin were trading at Rs 863.45 on the BSE inmorning trade, up 1.33 percent from its previous close.

PTI

Tags
Drugs Lupin Zymaxid Ophthalmic Solution
End of Article
Written by FP Archives

see more

Latest News
Find us on YouTube
Subscribe
End of Article

Top Stories

Russian drones over Poland: Trump’s tepid reaction a wake-up call for Nato?

Russian drones over Poland: Trump’s tepid reaction a wake-up call for Nato?

As Russia pushes east, Ukraine faces mounting pressure to defend its heartland

As Russia pushes east, Ukraine faces mounting pressure to defend its heartland

Why Mossad was not on board with Israel’s strike on Hamas in Qatar

Why Mossad was not on board with Israel’s strike on Hamas in Qatar

Turkey: Erdogan's police arrest opposition mayor Hasan Mutlu, dozens officials in corruption probe

Turkey: Erdogan's police arrest opposition mayor Hasan Mutlu, dozens officials in corruption probe

Russian drones over Poland: Trump’s tepid reaction a wake-up call for Nato?

Russian drones over Poland: Trump’s tepid reaction a wake-up call for Nato?

As Russia pushes east, Ukraine faces mounting pressure to defend its heartland

As Russia pushes east, Ukraine faces mounting pressure to defend its heartland

Why Mossad was not on board with Israel’s strike on Hamas in Qatar

Why Mossad was not on board with Israel’s strike on Hamas in Qatar

Turkey: Erdogan's police arrest opposition mayor Hasan Mutlu, dozens officials in corruption probe

Turkey: Erdogan's police arrest opposition mayor Hasan Mutlu, dozens officials in corruption probe

Top Shows

Vantage Firstpost America Firstpost Africa First Sports
Latest News About Firstpost
Most Searched Categories
  • Web Stories
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Tech/Auto
  • Entertainment
  • IPL 2025
NETWORK18 SITES
  • News18
  • Money Control
  • CNBC TV18
  • Forbes India
  • Advertise with us
  • Sitemap
Firstpost Logo

is on YouTube

Subscribe Now

Copyright @ 2024. Firstpost - All Rights Reserved

About Us Contact Us Privacy Policy Cookie Policy Terms Of Use
Home Video Shorts Live TV